When Fungal Infections Get Complex: Rethinking

Comprehensive Molecular Detection

From Pathogen Identification to a Broader Molecular Picture

Fungal infections can be difficult to diagnose. Clinical manifestations are often nonspecific, while conventional culture may require time to provide actionable microbiological information. In critically ill or immunocompromised patients, the diagnostic challenge can become even greater.

At the same time, fungal infections do not always occur in isolation. Fungal and bacterial pathogens may present with overlapping clinical features, while emerging antifungal resistance adds another layer of complexity.

This raises an important question:

When the differential diagnosis is broad, can we obtain a broader molecular picture within a single testing workflow?

Increasingly, international guidelines and expert consensus recognize molecular diagnostics as a complementary tool in fungal infection diagnosis—used alongside clinical assessment, culture, susceptibility testing, and other appropriate diagnostic methods.

What Do International Guidelines Tell Us?

The role of molecular testing in fungal diagnostics is evolving.

The IDSA guideline for aspergillosis recognizes PCR as a promising diagnostic approach and emphasizes that molecular results should be interpreted together with other diagnostic tests and the clinical context.

For selected high-risk patients with suspected invasive pulmonary aspergillosis, the American Thoracic Society recommends Aspergillus PCR in blood or serum and as part of BAL testing.

For invasive candidiasis, the IDSA guideline describes PCR as an adjunct to culture and highlights potential advantages including more rapid diagnosis, species identification, multiplex testing, and detection of molecular markers associated with antifungal resistance.

The message is not to replace conventional microbiology. It is to add complementary molecular information when broader or earlier microbiological insight is needed.

From Single-Pathogen Testing to Multiplex Detection

In complex infections, the potential pathogen spectrum can be broad. A workflow based on testing one suspected organism at a time may therefore require multiple assays and sequential investigations.

Multiplex molecular testing offers another approach: Investigate multiple clinically relevant targets within one molecular workflow.

This can be particularly useful when fungal and bacterial infections may overlap, when multiple pathogens are part of the differential diagnosis, or when resistance-associated molecular information is relevant to the diagnostic assessment.

Introducing the Macro & Micro-Test 32-Plex Fungal Nucleic Acid Detection Kit

The Macro & Micro-Test 32-Plex Fungal Nucleic Acid Detection Kit is a multiplex real-time PCR assay designed to simultaneously investigate fungal pathogens, selected bacterial pathogens, and resistance-associated molecular targets within a single test.

Broad Fungal Coverage

Multiple fungal pathogens can be investigated simultaneously, supporting a broader molecular assessment rather than a single-target approach.

Integrated Bacterial Detection

Selected bacterial targets are included to help address situations where bacterial and fungal infections may present with overlapping clinical features.

Resistance-Associated Molecular Targets

The panel includes ERG11 and mecA, providing molecular information associated with antifungal and antibacterial resistance mechanisms.

These molecular targets are intended to complement, rather than replace, phenotypic susceptibility testing and other microbiological methods.

Designed for Comprehensive Molecular Testing

The assay is designed to bring broad pathogen and resistance-associated molecular detection into a single workflow.

-Multiple specimen types: Surface samples, whole blood, and tissue homogenates

-Broad platform compatibility: Validated on major real-time PCR systems, including the Eudemon™ AIO800

-Practical laboratory use: Stable at 2–25°C with a 12-month shelf life

By combining fungal pathogens, selected bacterial pathogens, and resistance-associated molecular targets in one multiplex assay, the panel can help laboratories obtain a broader molecular view when the differential diagnosis is complex.

Why a Broader Molecular Picture Matters

Fungal diagnosis is rarely based on a single test. Culture remains essential in many clinical scenarios, particularly when organism recovery, species confirmation, or antimicrobial susceptibility testing is required.

Molecular testing adds another layer of information.By investigating multiple targets within one workflow, comprehensive molecular detection can help laboratories move beyond a narrow single-pathogen question toward a  broader assessment of clinically relevant microorganisms.

The value is not simply more targets. It is more relevant information within one integrated workflow.

More targets. One workflow. A broader molecular picture.

Advancing the Way We Approach Fungal Diagnostics

As fungal infections become increasingly complex, diagnostic strategies need to evolve accordingly.No single technology answers every clinical question.

The future lies in combining clinical assessment, conventional microbiology, susceptibility testing, and molecular diagnostics to generate the most meaningful information for each patient and each diagnostic scenario.

The Macro & Micro-Test 32-Plex Fungal Nucleic Acid Detection Kit is designed to contribute to this integrated approach by bringing comprehensive pathogen and resistance-associated molecular detection into one multiplex real-time PCR workflow.

Because better diagnosis starts with seeing more of the picture.

Macro & Micro-Test-Precise Diagnosis Shapes a Better Life